Alterity Therapeutics (ATHE) Other Non-Current Liabilities (2009 - 2025)

Alterity Therapeutics' Other Non-Current Liabilities history runs 16 years deep, the most recent figure standing at $617156.7 for Q4 2025.

• In Q4 2025, Other Non-Current Liabilities rose 60.79% year-over-year to $617156.7; the TTM figure through Dec 2025 stood at $617156.7 (up 60.79% YoY), while the FY2025 annual figure was $560960.6, up 10470.22% from the prior year.
• Other Non-Current Liabilities was $617156.7 for Q4 2025 at Alterity Therapeutics, up from $560960.6 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $617156.7 in Q4 2025 to a low of $349743.6 in Q2 2024.
• Historically, Other Non-Current Liabilities has averaged $461571.6 across 5 years, with a median of $453116.8 in 2022.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities dropped 28.24% in 2024, then jumped 60.79% in 2025.
• A 5-year view of Other Non-Current Liabilities shows it stood at $446642.3 in 2021, then gained by 2.9% to $459591.4 in 2022, then fell by 7.19% to $426546.5 in 2023, then dropped by 10.01% to $383839.2 in 2024, then surged by 60.79% to $617156.7 in 2025.
• The last three Other Non-Current Liabilities figures came in at $617156.7 (Q4 2025), $560960.6 (Q2 2025), and $383839.2 (Q4 2024), per Business Quant data.